Fortical Articles
Novo Gets Go-Ahead For hGH
19 March 1997
Lilly's Humatrope For Turner Syndrome
23 December 1996
Serostim Launched For Cachexia In USA
9 December 1996
Serono Labs' Saizen Approved In USA
21 October 1996
Unigene Initiate Phase III Trial With Osteoporosis Treatment
9 September 1996
Approval Of Unigene's IND For Fortical
5 August 1996
Recombinant Calcitonin In Osteoporosis
8 July 1996
Fortical Phase III Trials
1 July 1996
Sandoz Launches Nasal Calcitonin In USA
18 December 1995
USA Lags Foreign Approvals, PhRMA Demonstrates
16 October 1995
Sandoz' Calcitonin Spray Approved
11 September 1995
US OK For Miacalcin
4 September 1995
Sandoz Receives Recommended Approval In USA
6 March 1995
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- New study shows UCB's Neupro reduces NSBP in RLS patient
